The Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have transformed localization into a discipline focused on change management. It’s no longer a matter of “Translate once and then forget.” Instead, it demands ongoing lifecycle management.
In the fast-paced world of medical device manufacturing, safety is always a top priority. However, safety doesn’t just come from high-quality engineering or innovative design. It also hinges on clear communication, especially when it comes to labeling, instructions for use (IFUs), and safety documentation. With the implementation of the EU Medical Device Regulation (MDR 2017/745) and In-vitro Diagnostic Regulation (IVDR 2017/746), these materials are now subject to more stringent localization requirements than ever before.
Medical device localization is crucial for global market success. It goes beyond standard medical translations: it ensures that every product detail aligns with local language, culture, and strict healthcare regulations.
Medical translations are not just words on paper — they are a lifeline for patients, healthcare professionals, and medical device users worldwide. A single mistranslation can lead to misdiagnosis, ineffective treatment, or even death. Understanding the risks and knowing how to avoid them is critical for any healthcare provider, medical device manufacturer, or pharmaceutical company.
Entering new global markets offers huge growth opportunities for medical device manufacturers. However, success depends on more than technical innovation — it requires clear, accurate, and culturally appropriate communication. High-quality localization is the bridge that connects advanced medical devices with diverse patient groups, healthcare providers, and regulators worldwide.
In the highly regulated environment of EU clinical trials, safeguarding personal data and commercially confidential information (CCI) is critical – not only for legal compliance, but also for maintaining trust among stakeholders. For companies leveraging translation and localization services to support global clinical research, understanding how these services intersect with data protection regulations such as the GDPR and EMA policies is essential. Janus Worldwide plays a pivotal role in ensuring the confidentiality and security of sensitive information through industry-leading localization solutions.
